Baicalin attenuates collagen-induced arthritis via inhibition of JAK2-STAT3 signaling and regulation of Th17 cells in mice

  • Fengchun Sun
  • Wenjing GuEmail author
Research Article


This study focused on the potential therapeutic effect of Baicalin on collagen-induced arthritis (CIA) in mice and the underlying mechanisms. Baicalin (200 mg/kg) was administrated after the induction of CIA for 42 days. Therapeutic effects were evaluated by arthritic scores, X-rays and assessment of histopathological joint destruction. The production of TNF-α,IL-6,IL-17,IL-1β were also measured. The percentage of Th17 cells in splenocytes were determined by flow cytometry analysis. Our results showed that Baicalin treatment attenuated the severity of arthritis of CIA mice and reduced the levels of several cytokines. Further mechanistic investigations revealed that Baicalin suppressed the expression and phosphorylation of JAK2 and STAT3 protein in splenocytes tissue. Moreover, the percentage of Th17 cells in splenocytes also downregulated by Baicalin. Our experiment indicate that CIA mice can be alleviated by Baicalin treatment via inhibition of JAK2-STAT3 signaling and regulation of Th17 cells in mice.


Collagen-induced arthritis Baicalin JAK2 STAT3 Th17 cells 


Compliance with ethical standards

Conflict of interest

The author (s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.


  1. Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2(5):1269–1275. Google Scholar
  2. Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118(11):3537–3545. PubMedCentralGoogle Scholar
  3. Cai B, Cai JP, Luo YL, Chen C, Zhang S (2015) The specific roles of JAK/STAT signaling pathway in sepsis. Inflammation 38(4):1599–1608. Google Scholar
  4. Derksen V, Huizinga TWJ, van der Woude D (2017) The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol 39(4):437–446. PubMedCentralGoogle Scholar
  5. Edavalath S, Singh A, Soni N, Mohindra N, Kumar S, Misra R (2016) Peripheral blood T helper type 17 frequency shows an inverse correlation with disease activity and magnetic resonance imaging-based osteitis and erosions in disease-modifying anti-rheumatic drug- and steroid-naive established rheumatoid arthritis. Clin Exp Immunol 186(3):313–320. PubMedCentralGoogle Scholar
  6. Keystone EC (2005) B cells in rheumatoid arthritis: from hypothesis to the clinic. Rheumatology (Oxford) 44(Suppl 2):ii8–ii12. Google Scholar
  7. Kim WU, Lee WK, Ryoo JW, Kim SH, Kim J, Youn J, Min SY, Bae EY, Hwang SY, Park SH, Cho CS, Park JS, Kim HY (2002) Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. Arthritis Rheum 46(4):1109–1120Google Scholar
  8. Konttinen YT, Reitamo S, Ranki A, Hayry P, Kankaanapaa U, Wegelius O (1981) Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum 24(1):71–79Google Scholar
  9. Kubo M, Matsuda H, Tanaka M, Kimura Y, Okuda H, Higashino M, Tani T, Namba K, Arichi S (1984) Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. Chem Pharm Bull (Tokyo) 32(7):2724–2729Google Scholar
  10. Li BQ, Fu T, Gong WH, Dunlop N, Kung H, Yan Y, Kang J, Wang JM (2000) The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 49(3):295–306Google Scholar
  11. Lin CC, Shieh DE (1996) The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 24(1):31–36. Google Scholar
  12. Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167(2):1004–1013Google Scholar
  13. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7(6):429–442. Google Scholar
  14. Na HS, Kwon JE, Lee SH, Jhun J, Kim SM, Kim SY, Kim EK, Jung K, Park SH, Cho ML (2017) Th17 and IL-17 cause acceleration of inflammation and fat loss by inducing alpha2-Glycoprotein 1 (AZGP1) in rheumatoid arthritis with high-fat diet. Am J Pathol 187(5):1049–1058. Google Scholar
  15. Niu X, Deng S, Li S, Xi Y, Li C, Wang L, He D, Wang Z, Chen G (2016) Therapeutic effect of ergotope peptides on CIA by down-regulation of inflammatory and Th1/Th17 responses and induction of regulatory T cells. Mol Med 22.
  16. Noack M, Miossec P (2014) Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 13(6):668–677. Google Scholar
  17. O'Shea JJ, Plenge R (2012) JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36(4):542–550. PubMedCentralGoogle Scholar
  18. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93(3):385–395Google Scholar
  19. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11):1133–1141. PubMedCentralGoogle Scholar
  20. Rawlings JS, Rosler KM, Harrison DA (2004) The JAK/STAT signaling pathway. J Cell Sci 117(Pt 8):1281–1283. Google Scholar
  21. Son HJ, Lee SH, Lee SY, Kim EK, Yang EJ, Kim JK, Seo HB, Park SH, Cho ML (2017) Oncostatin M suppresses activation of IL-17/Th17 via SOCS3 regulation in CD4+ T cells. J Immunol 198(4):1484–1491. PubMedCentralGoogle Scholar
  22. Stolina M, Bolon B, Middleton S, Dwyer D, Brown H, Duryea D, Zhu L, Rohner A, Pretorius J, Kostenuik P, Feige U, Zack D (2009) The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis. J Clin Immunol 29(2):158–174. Google Scholar
  23. van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5(10):549–553. Google Scholar
  24. Wang HZ, Wang HH, Huang SS, Zhao H, Cao YG, Wang GZ, Wang D, Wang ZG, Liu YH (2014) Inhibitory effect of baicalin on collagen-induced arthritis in rats through the nuclear factor-kappaB pathway. J Pharmacol Exp Ther 350(2):435–443. Google Scholar
  25. Wang T, Li S, Yang Y, Zhang K, Dong S, Wang X, Liu X, Ren Y, Zhang M, Yan X, Li J, Zhang L (2016) T helper 17 and T helper 1 cells are increased but regulatory T cells are decreased in subchondral bone marrow microenvironment of patients with rheumatoid arthritis. Am J Transl Res 8(7):2956–2968PubMedCentralGoogle Scholar
  26. Wu Y, Zhang G, Wang X, Zhao Z, Wang T, Wang X, Li XF (2017) Early detection of rheumatoid arthritis in rats and humans with 99mTc-3PRGD2 scintigraphy: imaging synovial neoangiogenesis. Oncotarget 8(4):5753–5760. Google Scholar
  27. Xu L, Li J, Zhang Y, Zhao P, Zhang X (2017) Regulatory effect of baicalin on the imbalance of Th17/Treg responses in mice with allergic asthma. J Ethnopharmacol 208:199–206. Google Scholar
  28. Yang J, Yang X, Chu Y, Li M (2011) Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation. PLoS One 6(2):e17164. PubMedCentralGoogle Scholar
  29. Yang X, Yang J, Zou H (2013) Baicalin inhibits IL-17-mediated joint inflammation in murine adjuvant-induced arthritis. Clin Dev Immunol 2013:268065. PubMedCentralGoogle Scholar
  30. Yang R, Zhang Y, Wang L, Hu J, Wen J, Xue L, Tang M, Liu Z, Fu J (2017) Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis. Oncotarget 8(9):15420–15430. Google Scholar
  31. Zhang W, Sun Q, Gao X, Jiang Y, Li R, Ye J (2013) Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting alpha7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats. PLoS One 8(6):e66895. PubMedCentralGoogle Scholar

Copyright information

© The International CCN Society 2018

Authors and Affiliations

  1. 1.Department of Clinical LaboratoryAffiliated Hospital of Jining Medical UniversityJiningPeople’s Republic of China

Personalised recommendations